Dare Bioscience, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Dare Bioscience, Inc. (DARE) reported Increase (Decrease) in Prepaid Expense and Other Assets of $224.43 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2017-11-13
- Dare Bioscience, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2017-03-31 was $1.04M, a 497.13% increase year-over-year.
- Dare Bioscience, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2016-03-31 was $174.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month |
|---|---|---|
| 2017-09-30 | $224.43K 10-Q · filed 2017-11-13 | |
| 2017-03-31 | $1.04M 10-Q · filed 2017-05-12 | |
| 2016-03-31 | $174.00K 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |